Shin Hashiguchi

546 total citations
35 papers, 440 citations indexed

About

Shin Hashiguchi is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, Shin Hashiguchi has authored 35 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 15 papers in Rheumatology and 10 papers in Molecular Biology. Recurrent topics in Shin Hashiguchi's work include Sarcoma Diagnosis and Treatment (17 papers), Bone Tumor Diagnosis and Treatments (13 papers) and Oral and Maxillofacial Pathology (6 papers). Shin Hashiguchi is often cited by papers focused on Sarcoma Diagnosis and Treatment (17 papers), Bone Tumor Diagnosis and Treatments (13 papers) and Oral and Maxillofacial Pathology (6 papers). Shin Hashiguchi collaborates with scholars based in Japan and United States. Shin Hashiguchi's co-authors include Katsuyuki Kusuzaki, Hideyuki Takeshita, Hiroaki Murata, Tsukasa Ashihara, Yasusuke Hirasawa, Tsunehiko Nishimura, Yuya Hirasawa, Shinichiro Nakamura, Masaaki Hirata and Hitoshi Takeshita and has published in prestigious journals such as Cancer, British Journal of Cancer and Cancer Letters.

In The Last Decade

Shin Hashiguchi

35 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shin Hashiguchi Japan 12 293 126 113 108 97 35 440
Kyung-Ja Cho South Korea 12 254 0.9× 46 0.4× 71 0.6× 30 0.3× 106 1.1× 24 477
D. Matthew Gianferante United States 4 172 0.6× 49 0.4× 103 0.9× 35 0.3× 302 3.1× 8 513
Naoya Hirakawa Japan 12 122 0.4× 15 0.1× 215 1.9× 92 0.9× 135 1.4× 26 481
Per J. Bøhler Norway 13 98 0.3× 56 0.4× 151 1.3× 22 0.2× 196 2.0× 21 481
Shota Hasuda Japan 10 288 1.0× 41 0.3× 119 1.1× 16 0.1× 100 1.0× 13 513
Zi‐Zhan Li China 13 68 0.2× 59 0.5× 104 0.9× 13 0.1× 116 1.2× 41 403
Ayako Hirai Japan 14 216 0.7× 24 0.2× 206 1.8× 16 0.1× 81 0.8× 51 463
Zhengmao Lu China 10 65 0.2× 48 0.4× 80 0.7× 17 0.2× 151 1.6× 19 324
Wu‐tong Ju China 11 48 0.2× 44 0.3× 147 1.3× 24 0.2× 128 1.3× 27 358
Ningyang Jia China 13 156 0.5× 76 0.6× 98 0.9× 32 0.3× 39 0.4× 39 495

Countries citing papers authored by Shin Hashiguchi

Since Specialization
Citations

This map shows the geographic impact of Shin Hashiguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin Hashiguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin Hashiguchi more than expected).

Fields of papers citing papers by Shin Hashiguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shin Hashiguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin Hashiguchi. The network helps show where Shin Hashiguchi may publish in the future.

Co-authorship network of co-authors of Shin Hashiguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Shin Hashiguchi. A scholar is included among the top collaborators of Shin Hashiguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shin Hashiguchi. Shin Hashiguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Hidenori, et al.. (2022). Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers. Vaccine. 41(2). 365–371. 3 indexed citations
2.
Hashiguchi, Shin, Katsuyuki Kusuzaki, Hiroaki Murata, et al.. (2002). Acridine Orange Excited by Low-Dose Radiation Has a Strong Cytocidal Effect on Mouse Osteosarcoma. Oncology. 62(1). 85–93. 61 indexed citations
3.
Murata, Hiroaki, et al.. (2001). Extraabdominal desmoid tumor with dissemination detected by thallium-201 scintigraphy.. PubMed. 20(5C). 3963–6. 4 indexed citations
4.
Kusuzaki, Katsuyuki, Satoru Sugimoto, Hideyuki Takeshita, et al.. (2001). DNA cytofluorometric analysis of chondrocytes in human articular cartilages under normal aging or arthritic conditions. Osteoarthritis and Cartilage. 9(7). 664–670. 14 indexed citations
5.
Kusuzaki, Katsuyuki, et al.. (2001). Acridine orange induces binucleation in chondrocytes. Osteoarthritis and Cartilage. 9(2). 147–151. 5 indexed citations
6.
Nakamura, Satoaki, Katsuyuki Kusuzaki, Hiroaki Murata, et al.. (2001). Ceramic endoprosthesis for aggressive giant cell tumors near the knee: eight cases followed for more than 10 years. International Orthopaedics. 25(2). 104–106. 4 indexed citations
7.
Nakamura, Shinichiro, et al.. (2001). Extra-articular wide tumor resection and limb reconstruction in malignant bone tumors invading the knee joint. Oncology Reports. 8(2). 365–8. 12 indexed citations
8.
Murata, Hiroaki, et al.. (2001). Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.. PubMed. 20(5C). 3967–70. 4 indexed citations
9.
Kusuzaki, Katsuyuki, Hideyuki Takeshita, Hiroaki Murata, et al.. (2000). Photodynamic Inactivation with Acridine Orange on a Multidrug‐resistant Mouse Osteosarcoma Cell Line. Japanese Journal of Cancer Research. 91(4). 439–445. 52 indexed citations
10.
Kusuzaki, Katsuyuki, Hideyuki Takeshita, Hiroaki Murata, et al.. (2000). Total Tumor Cell Elimination with Minimum Damage to Normal Tissues in Musculoskeletal Sarcomas following Photodynamic Therapy with Acridine Orange. Oncology. 59(2). 174–180. 46 indexed citations
11.
Kusuzaki, Katsuyuki, et al.. (2000). Intracellular binding sites of acridine orange in living osteosarcoma cells.. PubMed. 20(2A). 971–5. 36 indexed citations
12.
Takeshita, Hideyuki, Katsuyuki Kusuzaki, Hiroaki Murata, et al.. (2000). Osteoblastic differentiation and P-glycoprotein multidrug resistance in a murine osteosarcoma model. British Journal of Cancer. 82(7). 1327–1331. 7 indexed citations
13.
Nakamura, Shinichiro, Katsuyuki Kusuzaki, Hiroaki Murata, et al.. (2000). More than 10 years of follow-up of two patients after total femur replacement for malignant bone tumor. International Orthopaedics. 24(3). 176–178. 16 indexed citations
14.
Murata, Hiroaki, et al.. (2000). Bilateral metachronous periosteal tibial amyloid tumors. Skeletal Radiology. 29(6). 346–348. 2 indexed citations
15.
Nakamura, Shinichiro, Katsuyuki Kusuzaki, Hiroaki Murata, et al.. (1999). Clinical outcome of total scapulectomy in 10 patients with primary malignant bone and soft-tissue tumors. Journal of Surgical Oncology. 72(3). 130–135. 16 indexed citations
16.
Murata, Hiroaki, et al.. (1999). Cytofluorometric DNA ploidy analysis in giant cell tumor of bone: histologic and prognostic value. Cancer Letters. 136(2). 223–229. 10 indexed citations
17.
Kusuzaki, Katsuyuki, Hideyuki Takeshita, Hiroaki Murata, et al.. (1999). Prognostic significance of DNA ploidy pattern in osteosarcomas in association with chemotherapy. Cancer Letters. 137(1). 27–33. 9 indexed citations
18.
Kusuzaki, Katsuyuki, Hideyuki Takeshita, Hiroaki Murata, et al.. (1999). Prognostic value of DNA ploidy response to chemotherapy in human osteosarcomas. Cancer Letters. 141(1-2). 131–138. 5 indexed citations
19.
Kusuzaki, Katsuyuki, Hideyuki Takeshita, Hiroaki Murata, et al.. (1999). Relationship between P-glycoprotein positivity, doxorubicin binding ability and histologic response to chemotherapy in osteosarcomas. Cancer Letters. 138(1-2). 203–208. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyung-Ja Cho Breakdown of academic impact, for papers by D. Matthew Gianferante Breakdown of academic impact, for papers by Naoya Hirakawa Breakdown of academic impact, for papers by Per J. Bøhler Breakdown of academic impact, for papers by Shota Hasuda Breakdown of academic impact, for papers by Zi‐Zhan Li Breakdown of academic impact, for papers by Ayako Hirai Breakdown of academic impact, for papers by Zhengmao Lu Breakdown of academic impact, for papers by Wu‐tong Ju Breakdown of academic impact, for papers by Ningyang Jia
Rankless by CCL
2026